Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MPT
951
Medical Properties Trust
MPT
$2.48B
| $10.1M | 0.01% |
539,177
-32,814
| -6% | -$581K |
|
952
Raymond James Financial
RJF
$34.5B
| $10.1M | 0.01% |
220,829
-268,338
| -55% | -$12.1M |
|
|
ICPT
953
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $10.1M | 0.01% |
211,246
-38,527
| -15% | -$2.98M |
|
954
PUT
Dell
DELL
$296B
| $10.1M | 0.01% |
363,032
+88,390
| +32% | +$1.99M |
|
955
CALL
IBM
IBM
$223B
| $10.1M | 0.01% |
87,446
-371,330
| -81% | -$43.1M |
|
956
Cardinal Health
CAH
$55.5B
| $10.1M | 0.01% |
193,184
-59,209
| -23% | -$3.05M |
|
957
Steris
STE
$23.3B
| $10.1M | 0.01% |
65,545
-7,078
| -10% | -$1.08M |
|
958
PUT
Texas Instruments
TXN
$256B
| $10.1M | 0.01% |
79,200
-288,200
| -78% | -$33.6M |
|
959
Loews
L
$23.3B
| $10M | 0.01% |
293,066
-152,616
| -34% | -$5.14M |
|
|
MRTX
960
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $10M | 0.01% |
87,995
-18,370
| -17% | -$1.78M |
|
961
iShares Core S&P 500 ETF
IVV
$904B
| $10M | 0.01% |
32,420
+794
| +3% | +$233K |
|
962
Tandem Diabetes Care
TNDM
$1.59B
| $10M | 0.01% |
101,480
+80,443
| +382% | +$6.42M |
|
|
GRMN
963
Garmin
GRMN
$60.4B
| $10M | 0.01% |
102,964
-30,938
| -23% | -$2.65M |
|
964
Principal Financial Group
PFG
$24.4B
| $10M | 0.01% |
241,508
-13,485
| -5% | -$492K |
|
|
GRUB
965
PUT
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $10M | 0.01% |
71,200
+38,500
| +118% | +$4.08M |
|
966
CALL
Gilead Sciences
GILD
$165B
| $9.99M | 0.01% |
129,900
-482,100
| -79% | -$36.9M |
|
967
HEICO Corp
HEI
$50.9B
| $9.93M | 0.01% |
99,657
+5,781
| +6% | +$534K |
|
|
IMMU
968
DELISTED
Immunomedics Inc
IMMU
| $9.92M | 0.01% |
279,960
-46,320
| -14% | -$1.35M |
|
969
CALL
XPO
XPO
$23.5B
| $9.9M | 0.01% |
370,677
+7,229
| +2% | +$173K |
|
970
Avery Dennison
AVY
$13.5B
| $9.89M | 0.01% |
86,678
-80,538
| -48% | -$8.85M |
|
971
Qualys
QLYS
$6.43B
| $9.88M | 0.01% |
94,952
+16,824
| +22% | +$1.76M |
|
972
CBRE Group
CBRE
$41.7B
| $9.86M | 0.01% |
218,054
-16,422
| -7% | -$708K |
|
973
CALL
Lockheed Martin
LMT
$139B
| $9.85M | 0.01% |
27,000
-7,800
| -22% | -$2.95M |
|
974
CALL
Paychex
PAYX
$43.1B
| $9.85M | 0.01% |
130,000
-59,800
| -32% | -$4.14M |
|
975
Americold
COLD
$4.17B
| $9.82M | 0.01% |
270,477
-349,782
| -56% | -$12M |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.